Gary Schiller

Gary Schiller

UNVERIFIED PROFILE

Are you Gary Schiller?   Register this Author

Register author
Gary Schiller

Gary Schiller

Publications by authors named "Gary Schiller"

Are you Gary Schiller?   Register this Author

97Publications

2244Reads

31Profile Views

How to address second and therapy-related acute myelogenous leukaemia.

Br J Haematol 2020 Jan;188(1):116-128

David Geffen School of Medicine at University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16354DOI Listing
January 2020

Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation.

Pediatr Blood Cancer 2019 Dec 20;66(12):e27940. Epub 2019 Aug 20.

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27940DOI Listing
December 2019

A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Cancers (Basel) 2019 Dec 26;12(1). Epub 2019 Dec 26.

Department of Medicine, Division of Hematology/Oncology Miller School of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12010074DOI Listing
December 2019

Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib.

Ann Hematol 2019 Oct 13;98(10):2443-2445. Epub 2019 Aug 13.

David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03780-1DOI Listing
October 2019

Disease characteristics of diffuse large B-cell lymphoma predicting relapse and survival after autologous stem cell transplantation: A single institution experience.

Hematol Oncol 2019 Oct 31. Epub 2019 Oct 31.

Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2690DOI Listing
October 2019

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.

N Engl J Med 2019 08;381(8):727-738

From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1903455
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1903455DOI Listing
August 2019

B-cell acute lymphoblastic leukemia as a secondary malignancy following diffuse large B-cell lymphoma.

Hematol Rep 2019 May 14;11(2):8100. Epub 2019 Jun 14.

Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/hr.2019.8100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589539PMC
May 2019

Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature.

Int J Hematol 2019 Mar 22;109(3):260-277. Epub 2019 Jan 22.

Hematological Malignancies/Stem Cell Transplantation Unit, Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Room 42-121 CHS, Los Angeles, CA, 90095, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12185-019-02594-1
Publisher Site
http://dx.doi.org/10.1007/s12185-019-02594-1DOI Listing
March 2019

Cardiac Complications in the Adult Bone Marrow Transplant Patient.

Curr Oncol Rep 2019 Mar 2;21(3):28. Epub 2019 Mar 2.

UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0774-6DOI Listing
March 2019

Liposomal Cytarabine-Daunorubicin (CPX-351) Extravasation: Case Report and Literature Review.

Anticancer Res 2018 Dec;38(12):6927-6930

Division of Hematology Oncology, David Geffen School of Medicine and University of California, Los Angeles, CA, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13070DOI Listing
December 2018

Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia.

Curr Treat Options Oncol 2018 10 25;19(12):63. Epub 2018 Oct 25.

UCLA Department of Hematology Oncology, 200 Medical Plaza, Suite 120, Los Angeles, CA, 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-018-0577-2DOI Listing
October 2018

Response.

Biol Blood Marrow Transplant 2018 09 17;24(9):1953-1954. Epub 2018 Jul 17.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.06.012DOI Listing
September 2018

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.

J Clin Oncol 2018 09 19;36(26):2684-2692. Epub 2018 Jul 19.

Jeffrey E. Lancet, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Geoffrey L. Uy, Washington University School of Medicine, St Louis, MO; Jorge E. Cortes, The University of Texas MD Anderson Cancer Center, Houston, TX; Laura F. Newell, Oregon Health & Science University, Portland, OR; Tara L. Lin, University of Kansas Medical Center, Kansas City, KS; Ellen K. Ritchie, Weill Cornell Medical College, New York; Jonathan E. Kolitz, Northwell Health System, Lake Success; Daniel H. Ryan, University of Rochester, Rochester, NY; Robert K. Stuart, Medical University of South Carolina, Charleston, SC; Stephen A. Strickland, Vanderbilt-Ingram Cancer Center, Nashville, TN; Donna Hogge, Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, British Columbia, Canada; Scott R. Solomon, The Leukemia Program at Northside Hospital Cancer Center Institute, Atlanta, GA; Richard M. Stone, Dana-Farber Cancer Institute, Boston, MA; Dale L. Bixby, University of Michigan, Grass Lake, MI; Gary J. Schiller, University of California-Los Angeles, Los Angeles; Matthew J. Wieduwilt, University of California-San Diego, La Jolla; Kamalika Banerjee, Michael Chiarella, Arthur C. Louie, Jazz Pharmaceuticals, Palo Alto; Bruno C. Medeiros, Stanford University School of Medicine, Stanford, CA; and Antje Hoering, Cancer Research and Biostatistics, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.6112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127025PMC
September 2018

Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Biol Blood Marrow Transplant 2018 08 16;24(8):1715-1720. Epub 2018 Mar 16.

David Geffen School of Medicine, University of California, Los Angeles, California; Division of Hematology-Oncology, Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.03.010DOI Listing
August 2018

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.

N Engl J Med 2018 04;378(16):1479-1493

From the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (A.A.T., M.K.); University of California, San Francisco, Benioff Children's Hospital, Oakland (M.C.W., E.V.), Lucile Salter Packard Children's Hospital at Stanford, Palo Alto (S.S.), and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (G.J.S.) - all in California; Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia (J.K., D.T.T.); Centenary Institute (J.E.J.R.), University of Sydney, Sydney Medical School (J.E.J.R., P.J.H.), and Royal Prince Alfred Hospital (J.E.J.R., P.J.H.), Camperdown, NSW, Australia; Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (J.-A.R., E.M., D.M., F.L., P.B., A.M., L.C., J.-S.D., F.S., F.M., V.B., C.B., O.H., M.D.M., S.B., M.C.), Groupe Hospitalier Universitaire Ouest (J.-A.R., A.M., L.C., M.C.), IMAGINE Institute (E.M., M.S., D.M., M.C.), Université Paris Descartes (M.S., C. Poirot, S.H.-B.-A.), Université Paris Diderot (H.P., T.L.), Pierre et Marie Curie University (C. Poirot), and Hôpital Cochin (J.-F.M.), Paris, CEA University Paris-Sud, Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses (E.P., Y.B., S.C., P.L.), Hôpital Louis-Mourier, Colombes (H.P., T.L.), Centre Hospitalier Intercommunal de Créteil, Créteil (C. Pondarré), and Hôpital Bicêtre, Le Kremlin-Bicêtre (S.H.-B.-A.) - all in France; Bluebird Bio, Cambridge (J.-A.R., S.S., G.V., O.N., R.W.R., D.D., A.P., L.S., M.A.), and Harvard Medical School, Brigham and Women's Hospital, Boston (P.L.) - both in Massachusetts; Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (S.H., U.A., P.L.); and the National Center for Tumor Diseases-German Cancer Research Center, Heidelberg, Germany (C.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1705342DOI Listing
April 2018

Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature.

Leuk Res Rep 2018 16;9:65-71. Epub 2018 Apr 16.

Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, LA, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2018.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993360PMC
April 2018

Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults.

Blood Rev 2018 03 21;32(2):122-129. Epub 2017 Sep 21.

Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine, University of California, Los Angeles, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2017.09.005DOI Listing
March 2018

Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.

J Clin Oncol 2018 03 30;36(9):859-866. Epub 2018 Jan 30.

Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905485PMC
March 2018

Persistent cytarabine and daunorubicin exposure after administration of novel liposomal formulation CPX-351: population pharmacokinetic assessment.

Cancer Chemother Pharmacol 2018 01 22;81(1):171-178. Epub 2017 Nov 22.

Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3484-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756117PMC
January 2018

Novel Cytogenetic Findings in a Case of Mixed Phenotype Acute Leukemia within the Context of a Complex Karyotype.

J Assoc Genet Technol 2017 ;43(1):20-22

Laboratory of Cytogenetics, Allina Health, Minneapolis, MN.

View Article

Download full-text PDF

Source
January 2017

Acute Myeloid Leukemia: How Do We Measure Success?

Curr Hematol Malig Rep 2016 12;11(6):528-536

UCLA Department of Medicine, Division of Hematology and Oncology, Aramont Foundation for Clinical/Translational Research in Human Malignancies, Room 42-121 Center for Health Sciences, David Geffen School of Medicine at UCLA, Los Angeles, 90095, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0346-xDOI Listing
December 2016

Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD-Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-Transplantation.

Biol Blood Marrow Transplant 2016 06 16;22(6):982-990. Epub 2016 Jan 16.

Weill Cornell Medical College, Division of Hematology/Oncology, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.01.013DOI Listing
June 2016

Preventive strategies for invasive Aspergillus in acute myelogenous leukemia.

Authors:
Gary Schiller

Clin Adv Hematol Oncol 2016 May;14(5):324-5

David Geffen School of Medicine at UCLA, Los Angeles, California.

View Article

Download full-text PDF

Source
May 2016

High-Intensity Induction in the Elderly.

Authors:
Gary J Schiller

Acta Haematol 2016 8;135(1):53-4. Epub 2015 Oct 8.

Hematological Malignancies/Stem Cell Transplantation, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, Calif., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000438481DOI Listing
January 2016

Emerging strategies for high-risk and relapsed/refractory acute myeloid leukemia: novel agents and approaches currently in clinical trials.

Blood Rev 2015 Jan 16;29(1):1-9. Epub 2014 Jul 16.

UCLA Department of Medicine, Division of Hematology and Oncology, Center for Health Sciences, Room 42-121, Los Angeles, CA 90095, USA; David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0268960X140005
Publisher Site
http://dx.doi.org/10.1016/j.blre.2014.07.002DOI Listing
January 2015

High-risk acute myelogenous leukemia: treatment today ... and tomorrow.

Authors:
Gary J Schiller

Hematology Am Soc Hematol Educ Program 2013 ;2013:201-8

1Hematological Malignancy/Stem Cell Transplant Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2013.1.201DOI Listing
December 2014

Evolving treatment strategies in patients with high-risk acute myeloid leukemia.

Authors:
Gary J Schiller

Leuk Lymphoma 2014 Nov 7;55(11):2438-48. Epub 2014 Mar 7.

Hematological Malignancy, Stem Cell Transplant Program, David Geffen School of Medicine at UCLA , Los Angeles, CA , USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2014.88
Publisher Site
http://dx.doi.org/10.3109/10428194.2014.881479DOI Listing
November 2014

Allogeneic transplantation as therapy for acute myelogenous leukemia in the elderly.

Authors:
Gary J Schiller

Biol Blood Marrow Transplant 2014 Apr 29;20(4):437-8. Epub 2014 Jan 29.

Stem Cell Transplant Program, David Geffen School of Medicine, University of California, Los Angeles, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.01.024DOI Listing
April 2014

Myelodysplasia.

Hematology 2013 Sep;18(5):307-8

UCLA School of Medicine, Center for the Health Sciences, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1179/1024533213Z.000000000221DOI Listing
September 2013

High-dose cytarabine (HD araC) in the treatment of leukemias: a review.

Curr Hematol Malig Rep 2013 Jun;8(2):141-8

Department of Internal Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-013-0156-3DOI Listing
June 2013

Secondary hemophagocytic lymphohistiocytosis in adults: an update on diagnosis and therapy.

Clin Adv Hematol Oncol 2012 Nov;10(11):726-32

Olive View-UCLA Medical Center, Department of Internal Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 91342, USA.

View Article

Download full-text PDF

Source
November 2012

Minimal residual disease as a predictive factor for relapse after allogeneic hematopoietic stem cell transplant in adult patients with acute myeloid leukemia in first and second complete remission.

Cancers (Basel) 2012 Jun 20;4(2):601-17. Epub 2012 Jun 20.

Hematological Malignancy, Stem Cell Transplant Program, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Room 42-121 CHS, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers4020601DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712693PMC
June 2012

Blastic plasmacytoid dendritic cell neoplasm.

Clin Adv Hematol Oncol 2012 Jan;10(1):60-2

Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
January 2012

Transplantation for congenital bone marrow failure syndromes.

Bone Marrow Res 2011 29;2011:849387. Epub 2010 Nov 29.

Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine at UCLA, University of California, 10833 Le Conte Avenue, Los Angeles, CA 90095-1752, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/849387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199936PMC
November 2011

Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.

Biol Blood Marrow Transplant 2011 Apr 9;17(4):507-15. Epub 2010 May 9.

Division of Hematology-Oncology, Department of Medicine, UCLA Medical Center, University of California-Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.04.017DOI Listing
April 2011

When a gold standard is made of tin.

Authors:
Gary J Schiller

Blood 2010 Nov;116(22):4386-7

David Geffen School of Medicine At UCLA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-08-300566DOI Listing
November 2010

Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia.

J Clin Oncol 2010 Feb 21;28(5):815-21. Epub 2009 Dec 21.

Cancer Therapy and Research Center at The University of Texas Health Science Center, 7979 Wurzbach Rd, Mail Code 8026, Urschel Tower, Suite 600, San Antonio, TX 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.24.2008DOI Listing
February 2010

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia.

J Clin Oncol 2010 Feb 21;28(4):556-61. Epub 2009 Dec 21.

Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.23.9178
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.23.9178DOI Listing
February 2010

Current status of acute myeloid leukemia treatment in the elderly.

Authors:
Gary Schiller

Clin Adv Hematol Oncol 2009 Sep;7(9):580-2

Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
September 2009

Myelodysplastic syndrome: An update on diagnosis and therapy.

Curr Hematol Malig Rep 2009 Jan;4(1):10-6

Department of Hematology/Oncology, University of California, Los Angeles, Box 957059, Suite 2333 PVUB, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-009-0002-9DOI Listing
January 2009

Standardized protocol to identify high-risk patients undergoing therapeutic apheresis procedures.

J Clin Apher 2008 ;23(3):111-5

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1732, USA. ucla.edu

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jca.20167DOI Listing
September 2008

Myelodysplastic syndrome: an update on diagnosis and therapy.

Curr Oncol Rep 2008 Sep;10(5):372-8

Department of Hematology/Oncology, University of California, Los Angeles, Box 957059, Suite 2333 PVUB, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-008-0058-zDOI Listing
September 2008

Acute myeloid leukemia in the elderly: conventional and novel treatment approaches.

Blood Rev 2008 Jul 22;22(4):221-34. Epub 2008 Apr 22.

Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2008.03.002DOI Listing
July 2008

Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol.

J Clin Apher 2008 ;23(2):66-73

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, California, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jca.20159
Publisher Site
http://dx.doi.org/10.1002/jca.20159DOI Listing
June 2008

Duodenal lymphoma: a rare and morbid tumor.

Am Surg 2007 Oct;73(10):1057-62

Division of General Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
October 2007

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Blood 2006 Oct 27;108(8):2745-54. Epub 2006 Jun 27.

Division of Surgical Oncology, Department of Surgery, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095-1782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-020263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895578PMC
October 2006

Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes.

J Clin Oncol 2006 Jun 1;24(16):2456-64. Epub 2006 May 1.

UCLA Division of Hematology-Oncology, University of California Los Angeles, San Diego, CA 90095, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.03.7903
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.03.7903DOI Listing
June 2006

Myelodysplasic syndromes: a comprehensive review.

Blood Rev 2005 Nov;19(6):301-19

Division of Hematology and Oncology, Department of Medicine, UCLA School of Medicine, Los Angeles, CA 90095-3075, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2005.01.004DOI Listing
November 2005

The evolution of antibodies into versatile tumor-targeting agents.

Clin Cancer Res 2005 Jan;11(1):129-38

Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
January 2005

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Blood 2003 Apr 14;101(7):2461-3. Epub 2002 Nov 14.

Department of Medicine, David Geffen School of Medicine, and the West Los Angeles Veterans Administration Hospital, University of California, Los Angeles 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-10-3235DOI Listing
April 2003

Treatment of Scedosporium apiospermum brain abscesses with posaconazole.

Clin Infect Dis 2002 Jun 16;34(12):1648-50. Epub 2002 May 16.

Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles School of Medicine, Los Angeles, CA, 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/340522DOI Listing
June 2002